Shows enhanced degradation of pharmaceuticals in membrane bioreactor-treated wastewater, indicating improved wastewater treatment methods.
The presence of pharmaceuticals in treated wastewater has become an environmental concern due to their persistence, biological activity, and incomplete removal in conventional wastewater treatment systems. In this study, a g-C3N4/rGO nanocomposite was synthesized via thermal polycondensation of melamine in the presence of reduced graphene oxide and evaluated as a photocatalyst for the degradation of selected pharmaceuticals in membrane bioreactor (MBR)-treated wastewater. The obtained materials were characterized using Fourier-transform infrared spectroscopy (FTIR–ATR), X-ray diffraction (XRD), nitrogen adsorption–desorption measurements (BET), Raman spectroscopy, scanning electron microscopy (SEM), and UV–Vis spectroscopy to evaluate their chemical structure, crystallinity, textural properties, morphology, and optical characteristics. Photocatalytic experiments were performed under UV irradiation using real wastewater spiked with carbamazepine, diclofenac, ibuprofen, and sulfamethoxazole at an initial concentration of 50 mg/L, selected to ensure reliable quantification under laboratory conditions. The complete removal of diclofenac and sulfamethoxazole was achieved within 30 min of treatment, while the presence of the nanocomposite enhanced the degradation efficiency of ibuprofen and carbamazepine by approximately 19% and 13%, respectively, compared to UV irradiation alone. The obtained results demonstrate the applicability of the investigated g-C3N4/rGO system for pharmaceutical degradation in real wastewater matrices and indicate its potential as a preliminary photocatalytic post-treatment approach.
No takes yet. Share an insight, caveat, or question.
Całus-Makowska et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: